questionsmedicales.fr
Cellules
Neurones
Neurofibres
Neurofibres : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Neuropathie
Examen neurologique
Électromyographie
Potentiels évoqués
Imagerie par résonance magnétique
Lésions nerveuses
Conduction nerveuse
Tests de conduction
Symptômes
5
Neuropathie périphérique
Réflexes
Neurofibres
Types de neuropathie
Prévention
5
Tabagisme
Vaisseaux sanguins
Traitements
5
Traitement
Thérapie physique
Analgésiques
Anticonvulsivants
Physiothérapie
Force musculaire
Intervention chirurgicale
Symptômes graves
Efficacité
Causes de neuropathie
Complications
5
Amputation
Lésions nerveuses
Troubles de la marche
Coordination
Dépression
Douleur chronique
Réversibilité
Traitement approprié
Facteurs de risque
5
Facteurs de risque
Diabète
Antécédents familiaux
Risque individuel
Diabète
Neuropathie périphérique
Carences nutritionnelles
Vitamines B
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres : Questions médicales les plus fréquentes",
"headline": "Neurofibres : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Neurofibres : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-06",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Neurofibres"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Neurones",
"url": "https://questionsmedicales.fr/mesh/D009474",
"about": {
"@type": "MedicalCondition",
"name": "Neurones",
"code": {
"@type": "MedicalCode",
"code": "D009474",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres adrénergiques",
"alternateName": "Adrenergic Fibers",
"url": "https://questionsmedicales.fr/mesh/D000320",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D000320",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Neurofibres autonomes postganglionnaires",
"alternateName": "Autonomic Fibers, Postganglionic",
"url": "https://questionsmedicales.fr/mesh/D001338",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres autonomes postganglionnaires",
"code": {
"@type": "MedicalCode",
"code": "D001338",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres sympathiques postganglionnaires",
"alternateName": "Sympathetic Fibers, Postganglionic",
"url": "https://questionsmedicales.fr/mesh/D017779",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres sympathiques postganglionnaires",
"code": {
"@type": "MedicalCode",
"code": "D017779",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.100.800"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Axones",
"alternateName": "Axons",
"url": "https://questionsmedicales.fr/mesh/D001369",
"about": {
"@type": "MedicalCondition",
"name": "Axones",
"code": {
"@type": "MedicalCode",
"code": "D001369",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Segment initial de l'axone",
"alternateName": "Axon Initial Segment",
"url": "https://questionsmedicales.fr/mesh/D000071040",
"about": {
"@type": "MedicalCondition",
"name": "Segment initial de l'axone",
"code": {
"@type": "MedicalCode",
"code": "D000071040",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cônes de croissance",
"alternateName": "Growth Cones",
"url": "https://questionsmedicales.fr/mesh/D020439",
"about": {
"@type": "MedicalCondition",
"name": "Cônes de croissance",
"code": {
"@type": "MedicalCode",
"code": "D020439",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fibres moussues de l'hippocampe",
"alternateName": "Mossy Fibers, Hippocampal",
"url": "https://questionsmedicales.fr/mesh/D019599",
"about": {
"@type": "MedicalCondition",
"name": "Fibres moussues de l'hippocampe",
"code": {
"@type": "MedicalCode",
"code": "D019599",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.438"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Terminaisons présynaptiques",
"alternateName": "Presynaptic Terminals",
"url": "https://questionsmedicales.fr/mesh/D017729",
"about": {
"@type": "MedicalCondition",
"name": "Terminaisons présynaptiques",
"code": {
"@type": "MedicalCode",
"code": "D017729",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Collatéraux de Schaffer",
"alternateName": "Schaffer Collaterals",
"url": "https://questionsmedicales.fr/mesh/D000094282",
"about": {
"@type": "MedicalCondition",
"name": "Collatéraux de Schaffer",
"code": {
"@type": "MedicalCode",
"code": "D000094282",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.875"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Neurofibres cholinergiques",
"alternateName": "Cholinergic Fibers",
"url": "https://questionsmedicales.fr/mesh/D002799",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres cholinergiques",
"code": {
"@type": "MedicalCode",
"code": "D002799",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.234"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres autonomes préganglionnaires",
"alternateName": "Autonomic Fibers, Preganglionic",
"url": "https://questionsmedicales.fr/mesh/D001339",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres autonomes préganglionnaires",
"code": {
"@type": "MedicalCode",
"code": "D001339",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.234.060"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Neurofibres parasympathiques postganglionnaires",
"alternateName": "Parasympathetic Fibers, Postganglionic",
"url": "https://questionsmedicales.fr/mesh/D017777",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres parasympathiques postganglionnaires",
"code": {
"@type": "MedicalCode",
"code": "D017777",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.234.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Gaine de myéline",
"alternateName": "Myelin Sheath",
"url": "https://questionsmedicales.fr/mesh/D009186",
"about": {
"@type": "MedicalCondition",
"name": "Gaine de myéline",
"code": {
"@type": "MedicalCode",
"code": "D009186",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.512.560"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gaine de Schwann",
"alternateName": "Neurilemma",
"url": "https://questionsmedicales.fr/mesh/D009441",
"about": {
"@type": "MedicalCondition",
"name": "Gaine de Schwann",
"code": {
"@type": "MedicalCode",
"code": "D009441",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.512.560.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Noeuds de Ranvier",
"alternateName": "Ranvier's Nodes",
"url": "https://questionsmedicales.fr/mesh/D011901",
"about": {
"@type": "MedicalCondition",
"name": "Noeuds de Ranvier",
"code": {
"@type": "MedicalCode",
"code": "D011901",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.512.560.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Neurofibres non-myélinisées",
"alternateName": "Nerve Fibers, Unmyelinated",
"url": "https://questionsmedicales.fr/mesh/D036421",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres non-myélinisées",
"code": {
"@type": "MedicalCode",
"code": "D036421",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.756"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres",
"alternateName": "Nerve Fibers",
"code": {
"@type": "MedicalCode",
"code": "D009412",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Z V Surnina",
"url": "https://questionsmedicales.fr/author/Z%20V%20Surnina",
"affiliation": {
"@type": "Organization",
"name": "Krasnov Research Institute of Eye Diseases, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "S E Avetisov",
"url": "https://questionsmedicales.fr/author/S%20E%20Avetisov",
"affiliation": {
"@type": "Organization",
"name": "Krasnov Research Institute of Eye Diseases, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "Yao-Chuan Chang",
"url": "https://questionsmedicales.fr/author/Yao-Chuan%20Chang",
"affiliation": {
"@type": "Organization",
"name": "Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, 11030, USA."
}
},
{
"@type": "Person",
"name": "Stavros Zanos",
"url": "https://questionsmedicales.fr/author/Stavros%20Zanos",
"affiliation": {
"@type": "Organization",
"name": "Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, 11030, USA. Electronic address: szanos@northwell.edu."
}
},
{
"@type": "Person",
"name": "Elçin Tunçkol",
"url": "https://questionsmedicales.fr/author/El%C3%A7in%20Tun%C3%A7kol",
"affiliation": {
"@type": "Organization",
"name": "Bernstein Center for Computational Neuroscience Berlin, Humboldt-Universität zu Berlin, Philippstrasse 13, Haus 6, Berlin, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "How To Read a Network Meta-analysis.",
"datePublished": "2023-11-03",
"url": "https://questionsmedicales.fr/article/37925328",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.euf.2023.10.018"
}
},
{
"@type": "ScholarlyArticle",
"name": "Methodological quality of network meta-analysis in dentistry: a meta-research.",
"datePublished": "2023-07-10",
"url": "https://questionsmedicales.fr/article/37436290",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/1807-3107bor-2023.vol37.0062"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of non-pharmacological interventions for adults with subjective cognitive decline: a network meta-analysis and component network meta-analysis.",
"datePublished": "2024-06-27",
"url": "https://questionsmedicales.fr/article/38937777",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12916-024-03491-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Network meta-interpolation: Effect modification adjustment in network meta-analysis using subgroup analyses.",
"datePublished": "2022-11-04",
"url": "https://questionsmedicales.fr/article/36283960",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jrsm.1608"
}
},
{
"@type": "ScholarlyArticle",
"name": "Treatments for alopecia areata: a network meta-analysis.",
"datePublished": "2023-10-23",
"url": "https://questionsmedicales.fr/article/37870096",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/14651858.CD013719.pub2"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Neurones",
"item": "https://questionsmedicales.fr/mesh/D009474"
},
{
"@type": "ListItem",
"position": 4,
"name": "Neurofibres",
"item": "https://questionsmedicales.fr/mesh/D009412"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Neurofibres - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Neurofibres",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Neurofibres",
"description": "Comment diagnostiquer une neuropathie ?\nQuels tests pour évaluer les neurofibres ?\nLes IRM sont-elles utiles pour les neurofibres ?\nQuels signes indiquent une atteinte des neurofibres ?\nComment évaluer la conduction nerveuse ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Network+Meta-Analysis#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Neurofibres",
"description": "Quels sont les symptômes d'une neuropathie ?\nComment se manifeste une neuropathie périphérique ?\nLes symptômes varient-ils selon le type de neurofibres ?\nPeut-on avoir des symptômes sans lésions visibles ?\nLes symptômes s'aggravent-ils avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Network+Meta-Analysis#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Neurofibres",
"description": "Comment prévenir les neuropathies ?\nL'exercice régulier aide-t-il à prévenir les neuropathies ?\nLes habitudes alimentaires influencent-elles les neurofibres ?\nFumer augmente-t-il le risque de neuropathie ?\nLe stress a-t-il un impact sur les neurofibres ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Network+Meta-Analysis#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Neurofibres",
"description": "Quels traitements existent pour les neuropathies ?\nLes médicaments peuvent-ils soulager la douleur nerveuse ?\nLa physiothérapie aide-t-elle les patients ?\nQuand envisager une intervention chirurgicale ?\nLes traitements sont-ils efficaces pour tous ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Network+Meta-Analysis#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Neurofibres",
"description": "Quelles complications peuvent survenir avec une neuropathie ?\nLa neuropathie peut-elle entraîner des amputations ?\nLes troubles de la marche sont-ils une complication ?\nPeut-on développer une dépression à cause de la neuropathie ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Network+Meta-Analysis#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Neurofibres",
"description": "Quels sont les principaux facteurs de risque de neuropathie ?\nL'âge influence-t-il le risque de neuropathie ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe diabète est-il un facteur de risque majeur ?\nLes carences nutritionnelles augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Network+Meta-Analysis#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une neuropathie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen neurologique, des tests électrophysiologiques et des analyses sanguines sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer les neurofibres ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'électromyographie (EMG) et les potentiels évoqués sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les IRM sont-elles utiles pour les neurofibres ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les IRM peuvent visualiser les lésions nerveuses et les anomalies des neurofibres."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une atteinte des neurofibres ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs, des engourdissements ou une faiblesse musculaire peuvent indiquer une atteinte."
}
},
{
"@type": "Question",
"name": "Comment évaluer la conduction nerveuse ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de conduction nerveuse mesurent la vitesse des signaux dans les neurofibres."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une neuropathie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur, picotements, faiblesse musculaire et perte de sensation."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une neuropathie périphérique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des douleurs, des engourdissements et des réflexes diminués."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de neurofibres ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent du type de neurofibres affectées (sensitives, motrices)."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans lésions visibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes peuvent survenir sans lésions visibles sur les examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Les symptômes s'aggravent-ils avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, les symptômes peuvent s'aggraver progressivement sans traitement."
}
},
{
"@type": "Question",
"name": "Comment prévenir les neuropathies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain, contrôler le diabète et éviter les toxines peuvent aider."
}
},
{
"@type": "Question",
"name": "L'exercice régulier aide-t-il à prévenir les neuropathies ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier améliore la circulation sanguine et la santé nerveuse."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles les neurofibres ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée riche en vitamines B peut soutenir la santé nerveuse."
}
},
{
"@type": "Question",
"name": "Fumer augmente-t-il le risque de neuropathie ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut endommager les vaisseaux sanguins et affecter les nerfs."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les neurofibres ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut exacerber les symptômes nerveux et affecter la santé globale."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les neuropathies ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent médicaments, thérapies physiques et interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils soulager la douleur nerveuse ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des analgésiques et des anticonvulsivants sont souvent prescrits pour soulager la douleur."
}
},
{
"@type": "Question",
"name": "La physiothérapie aide-t-elle les patients ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie peut améliorer la force musculaire et la coordination."
}
},
{
"@type": "Question",
"name": "Quand envisager une intervention chirurgicale ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une chirurgie est envisagée si les symptômes sont graves et ne répondent pas aux traitements conservateurs."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces pour tous ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité des traitements varie selon la cause et la gravité de la neuropathie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une neuropathie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections, des blessures et des problèmes d'équilibre."
}
},
{
"@type": "Question",
"name": "La neuropathie peut-elle entraîner des amputations ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des lésions nerveuses sévères peuvent augmenter le risque d'amputation, surtout chez les diabétiques."
}
},
{
"@type": "Question",
"name": "Les troubles de la marche sont-ils une complication ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la neuropathie peut affecter la coordination et entraîner des troubles de la marche."
}
},
{
"@type": "Question",
"name": "Peut-on développer une dépression à cause de la neuropathie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur chronique et les limitations fonctionnelles peuvent contribuer à la dépression."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de neuropathie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le diabète, l'alcoolisme, les infections et certaines maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de neuropathie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de neuropathie augmente avec l'âge en raison de la dégradation nerveuse."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de neuropathie peuvent augmenter le risque individuel."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque majeur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète est l'un des principaux facteurs de risque de neuropathie périphérique."
}
},
{
"@type": "Question",
"name": "Les carences nutritionnelles augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des carences en vitamines B et en acide folique peuvent augmenter le risque de neuropathie."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 01/04/2025
Contenu vérifié selon les dernières recommandations médicales
7 publications dans cette catégorie
Affiliations :
Krasnov Research Institute of Eye Diseases, Moscow, Russia.
5 publications dans cette catégorie
Affiliations :
Krasnov Research Institute of Eye Diseases, Moscow, Russia.
Sechenov First Moscow State Medical University, Moscow, Russia.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, 11030, USA.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, 11030, USA. Electronic address: szanos@northwell.edu.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Bernstein Center for Computational Neuroscience Berlin, Humboldt-Universität zu Berlin, Philippstrasse 13, Haus 6, Berlin, Germany.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Institute for Integrative Neuroanatomy, Charité - Universitätsmedizin Berlin, CCM, Philippstrasse 12, 10115, Berlin, Germany.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Bernstein Center for Computational Neuroscience Berlin, Humboldt-Universität zu Berlin, Philippstrasse 13, Haus 6, Berlin, Germany. michael.brecht@bccn-berlin.de.
NeuroCure Cluster of Excellence, Humboldt-Universität zu Berlin, Berlin, Germany. michael.brecht@bccn-berlin.de.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Clinical Laboratory for Bionic Extremity Reconstruction, Department of Plastic, Reconstructive and Aesthetic Surgery, Medical University of Vienna, Vienna, Austria.
Center for Biomedical Research, Medical University of Vienna, Vienna, Austria.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Center for Anatomy and Cell Biology, Medical University of Vienna, Vienna, Vienna Austria.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Clinical Laboratory for Bionic Extremity Reconstruction, Department of Plastic, Reconstructive and Aesthetic Surgery, Medical University of Vienna, Vienna, Austria oskar.aszmann@meduniwien.ac.at.
Department of Plastic, Reconstructive and Aesthetic Surgery, Medical University of Vienna, Vienna, Austria.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Research Institute of Eye Disease, 11A Rossolimo St., Moscow, Russian Federation, 119021.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do Province.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts.
Publications dans "Neurofibres" :
2 publications dans cette catégorie
Affiliations :
Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts.
Publications dans "Neurofibres" :
1 publication dans cette catégorie
Publications dans "Neurofibres" :
1 publication dans cette catégorie
Affiliations :
Indiana University School of Optometry, Bloomington, Indiana.
Publications dans "Neurofibres" :
1 publication dans cette catégorie
Affiliations :
Indiana University School of Optometry, Bloomington, Indiana.
Publications dans "Neurofibres" :
1 publication dans cette catégorie
Affiliations :
Department of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Neurofibres" :
1 publication dans cette catégorie
Affiliations :
Department of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Neurofibres" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, University of Würzburg, Josef-Schneider-Str. 11, 97080 Würzburg, Germany.
Publications dans "Neurofibres" :
Network meta-analysis (NMA) expands upon traditional meta-analysis by integrating three or more interventions. This allows comparing interventions using evidence from trials that have compared pairs o...
This meta-research aimed to provide an overview of the methodological quality and risk of bias of network meta-analyses (NMA) in dentistry. Searches for NMA of randomized clinical trials with clinical...
Non-pharmacological interventions have a myriad of available intervention options and contain multiple components. Whether specific components of non-pharmacological interventions or combinations are ...
PubMed, Embase, Cochrane, CINAHL, PsycINFO, CENTRAL, Web of Science, and China's two largest databases, CNKI and Wanfang, were searched from inception to 22nd, January 2023. Randomized controlled tria...
A total of 39 trials with 2959 patients were included (range of mean ages, 58.79-77.41 years). Resistance exercise might be the optimal intervention for reducing memory complaints in adults with subje...
The form of physical activity performed appears to be more beneficial than cognitive interventions in reducing subjective memory complaints for adults with subjective cognitive decline, and this diffe...
PROSPERO registry number. CRD42022355363....
Effect modification (EM) may cause bias in network meta-analysis (NMA). Existing population adjustment NMA methods use individual patient data to adjust for EM but disregard available subgroup informa...
Alopecia areata is an autoimmune disease leading to nonscarring hair loss on the scalp or body. There are different treatments including immunosuppressants, hair growth stimulants, and contact immunot...
To assess the benefits and harms of the treatments for alopecia areata (AA), alopecia totalis (AT), and alopecia universalis (AU) in children and adults....
The Cochrane Skin Specialised Register, CENTRAL, MEDLINE, Embase, ClinicalTrials.gov and WHO ICTRP were searched up to July 2022....
We included randomised controlled trials (RCTs) that evaluated classical immunosuppressants, biologics, small molecule inhibitors, contact immunotherapy, hair growth stimulants, and other therapies in...
We used the standard procedures expected by Cochrane including assessment of risks of bias using RoB2 and the certainty of the evidence using GRADE. The primary outcomes were short-term hair regrowth ...
We included 63 studies that tested 47 different treatments in 4817 randomised participants. All trials used a parallel-group design except one that used a cross-over design. The mean sample size was 7...
We found that treatment with baricitinib results in an increase in short- and long-term hair regrowth compared to placebo. Although we found inconclusive results for the risk of serious adverse effect...
Network meta-analysis combines direct and indirect evidence to compare multiple treatments. As direct evidence for one treatment contrast may be indirect evidence for other treatment contrasts, biases...
Evidence has shown that private industry-sponsored randomized controlled trials (RCTs) and meta-analyses are more likely to report intervention-favourable results compared with other sources of fundin...
To (a) explore the recommendation rate of industry-sponsored NMAs on their company's intervention, and (b) assess reporting in NMAs of pharmacologic interventions according to their funding type....
Design: Scoping review of published NMAs with RCTs....
We used a pre-existing NMA database including 1,144 articles from MEDLINE, EMBASE and Cochrane Database of Systematic Reviews, published between January 2013 and July 2018....
NMAs with transparent funding information and comparing pharmacologic interventions with/without placebo....
We captured whether NMAs recommended their own or another company's intervention, classified NMAs according to their primary outcome findings (i.e., statistical significance and direction of effect), ...
We retrieved 658 NMAs, which reported a median of 23 items in the PRISMA-NMA checklist (interquartile range [IQR]: 21-26). NMAs were categorized as 314 publicly-sponsored (PRISMA-NMA median 24.5, IQR ...
Differences in completeness of reporting and author characteristics were apparent among NMAs with different types of funding. Publicly-sponsored NMAs had the best reporting and published their finding...
Therapy for myasthenia gravis (MG) is undergoing a profound change, with new treatments being tested. These include complement inhibitors and neonatal Fc receptor (FcRn) blockers. The aim of this stud...
We assessed statistical heterogeneity across trials based on the Cochrane Q test and I...
We observed an overall mean Myasthenia Gravis-Activities of Daily Living scale (MG-ADL) score change of -2.17 points (95% confidence interval [CI] -2.67, -1.67; p < 0.001) as compared to placebo. No s...
Anti-complement and FcRn treatments both proved to be effective in MG patients, whereas rituximab did not show a significant benefit for patients. Within the limitations of this meta-analysis, includi...
Aerobic exercise is widely recognized for improving mental health and reducing negative emotions, including anxiety. However, research on its role in preventing and treating postpartum depression (PPD...
We conducted a quantitative systematic review of the study in 5 representative databases for the effect of aerobic exercise on PPD. Meta-analysis and network meta-analysis were performed with Review-M...
Twenty-six studies with 2,867 participants were eventually included and the efficacy of aerobic exercise in preventing and treating postpartum depression is significant compared to standard care. (MD ...
The efficacy of aerobic exercise in preventing and treating postpartum depression is significant compared to standard care, with a greater emphasis on prevention. The optimal prescribed exercise volum...
Mounting evidence suggests that breast reduction surgery displays higher rates of surgical site infections (SSI) than initially presumed. Objective of this network meta-analysis is to evaluate the eff...
A network meta-analysis was conducted using a predetermined protocol after searching the electronic databases MEDLINE, Scopus, the Cochrane Library and US National Institutes of Health Ongoing Trials ...
A total of 10 studies was included in the analysis involving 1331 patients. All but one study controlled for major risk factors, and no differences were observed in patients' baseline characteristics....
Antibiotics mitigate the SSI rate after breast reduction. This meta-analysis provides an evidence-based strategy to optimize antibiotic administration. Further research is needed though to examine ant...
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Inst...